nodes	percent_of_prediction	percent_of_DWPC	metapath
Finasteride—CYP3A7—Paclitaxel—ovarian cancer	0.125	0.156	CbGbCtD
Finasteride—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.125	0.156	CbGbCtD
Finasteride—CYP3A5—Paclitaxel—ovarian cancer	0.0938	0.117	CbGbCtD
Finasteride—CYP3A7—Docetaxel—ovarian cancer	0.0904	0.113	CbGbCtD
Finasteride—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0904	0.113	CbGbCtD
Finasteride—CYP3A4—Topotecan—ovarian cancer	0.0739	0.0922	CbGbCtD
Finasteride—CYP3A5—Docetaxel—ovarian cancer	0.0678	0.0846	CbGbCtD
Finasteride—CYP3A4—Vinorelbine—ovarian cancer	0.0521	0.065	CbGbCtD
Finasteride—CYP3A4—Paclitaxel—ovarian cancer	0.0366	0.0457	CbGbCtD
Finasteride—CYP3A4—Docetaxel—ovarian cancer	0.0264	0.033	CbGbCtD
Finasteride—CYP3A4—Doxorubicin—ovarian cancer	0.0197	0.0246	CbGbCtD
Finasteride—Neoplasm malignant—Altretamine—ovarian cancer	0.0126	0.0734	CcSEcCtD
Finasteride—Neoplasm—Altretamine—ovarian cancer	0.0097	0.0567	CcSEcCtD
Finasteride—Dydrogesterone—PGR—ovarian cancer	0.00665	0.554	CrCbGaD
Finasteride—Breast cancer—Docetaxel—ovarian cancer	0.00454	0.0265	CcSEcCtD
Finasteride—Neoplasm malignant—Chlorambucil—ovarian cancer	0.00447	0.0261	CcSEcCtD
Finasteride—AKR1D1—female reproductive system—ovarian cancer	0.00412	0.265	CbGeAlD
Finasteride—Neoplasm malignant—Melphalan—ovarian cancer	0.00389	0.0227	CcSEcCtD
Finasteride—Neoplasm—Chlorambucil—ovarian cancer	0.00345	0.0201	CcSEcCtD
Finasteride—AKR1D1—testis—ovarian cancer	0.00333	0.214	CbGeAlD
Finasteride—Neoplasm—Topotecan—ovarian cancer	0.00307	0.0179	CcSEcCtD
Finasteride—Neoplasm—Melphalan—ovarian cancer	0.00301	0.0176	CcSEcCtD
Finasteride—Asthenia—Altretamine—ovarian cancer	0.00275	0.016	CcSEcCtD
Finasteride—Infection—Carboplatin—ovarian cancer	0.00263	0.0154	CcSEcCtD
Finasteride—Prostatic disorder—Epirubicin—ovarian cancer	0.00263	0.0153	CcSEcCtD
Finasteride—Dizziness—Altretamine—ovarian cancer	0.00253	0.0148	CcSEcCtD
Finasteride—SRD5A1—gonad—ovarian cancer	0.00247	0.159	CbGeAlD
Finasteride—Prostatic disorder—Doxorubicin—ovarian cancer	0.00243	0.0142	CcSEcCtD
Finasteride—Pain—Carboplatin—ovarian cancer	0.00226	0.0132	CcSEcCtD
Finasteride—Tenderness—Paclitaxel—ovarian cancer	0.00224	0.0131	CcSEcCtD
Finasteride—SRD5A1—female reproductive system—ovarian cancer	0.0022	0.142	CbGeAlD
Finasteride—SRD5A1—testis—ovarian cancer	0.00178	0.114	CbGeAlD
Finasteride—Neoplasm—Paclitaxel—ovarian cancer	0.00177	0.0103	CcSEcCtD
Finasteride—Rhinitis—Topotecan—ovarian cancer	0.00171	0.00999	CcSEcCtD
Finasteride—Pharyngitis—Topotecan—ovarian cancer	0.00169	0.00989	CcSEcCtD
Finasteride—Swelling—Paclitaxel—ovarian cancer	0.00161	0.00939	CcSEcCtD
Finasteride—Injury—Paclitaxel—ovarian cancer	0.00154	0.00901	CcSEcCtD
Finasteride—Immune system disorder—Topotecan—ovarian cancer	0.00154	0.009	CcSEcCtD
Finasteride—Angioedema—Chlorambucil—ovarian cancer	0.00152	0.0089	CcSEcCtD
Finasteride—Immune system disorder—Melphalan—ovarian cancer	0.00151	0.00881	CcSEcCtD
Finasteride—Neoplasm—Docetaxel—ovarian cancer	0.0015	0.00875	CcSEcCtD
Finasteride—Swelling—Docetaxel—ovarian cancer	0.00136	0.00796	CcSEcCtD
Finasteride—Angioedema—Topotecan—ovarian cancer	0.00136	0.00792	CcSEcCtD
Finasteride—Infection—Chlorambucil—ovarian cancer	0.00135	0.0079	CcSEcCtD
Finasteride—Progesterone—PGR—ovarian cancer	0.00135	0.112	CrCbGaD
Finasteride—Immune system disorder—Vinorelbine—ovarian cancer	0.00132	0.0077	CcSEcCtD
Finasteride—Neoplasm malignant—Epirubicin—ovarian cancer	0.00131	0.00764	CcSEcCtD
Finasteride—Orthostatic hypotension—Paclitaxel—ovarian cancer	0.0013	0.00757	CcSEcCtD
Finasteride—Breast disorder—Paclitaxel—ovarian cancer	0.00128	0.00749	CcSEcCtD
Finasteride—Progesterone—CYP1B1—ovarian cancer	0.00126	0.105	CrCbGaD
Finasteride—Influenza—Paclitaxel—ovarian cancer	0.00123	0.00716	CcSEcCtD
Finasteride—Neoplasm malignant—Doxorubicin—ovarian cancer	0.00121	0.00707	CcSEcCtD
Finasteride—Infection—Topotecan—ovarian cancer	0.0012	0.00703	CcSEcCtD
Finasteride—Testosterone—CYP1B1—ovarian cancer	0.00119	0.0991	CrCbGaD
Finasteride—Bronchitis—Paclitaxel—ovarian cancer	0.00118	0.00689	CcSEcCtD
Finasteride—Infection—Melphalan—ovarian cancer	0.00118	0.00688	CcSEcCtD
Finasteride—Pain—Chlorambucil—ovarian cancer	0.00116	0.0068	CcSEcCtD
Finasteride—Angioedema—Vinorelbine—ovarian cancer	0.00116	0.00678	CcSEcCtD
Finasteride—Hypotension—Melphalan—ovarian cancer	0.00111	0.00648	CcSEcCtD
Finasteride—Orthostatic hypotension—Docetaxel—ovarian cancer	0.0011	0.00641	CcSEcCtD
Finasteride—Breast disorder—Docetaxel—ovarian cancer	0.00109	0.00635	CcSEcCtD
Finasteride—Urticaria—Chlorambucil—ovarian cancer	0.00108	0.00632	CcSEcCtD
Finasteride—Dyspnoea—Topotecan—ovarian cancer	0.00108	0.00631	CcSEcCtD
Finasteride—Dyspnoea—Melphalan—ovarian cancer	0.00106	0.00618	CcSEcCtD
Finasteride—Pain—Topotecan—ovarian cancer	0.00104	0.00605	CcSEcCtD
Finasteride—Infection—Vinorelbine—ovarian cancer	0.00103	0.00601	CcSEcCtD
Finasteride—Sinusitis—Paclitaxel—ovarian cancer	0.00103	0.00599	CcSEcCtD
Finasteride—Pain—Melphalan—ovarian cancer	0.00101	0.00593	CcSEcCtD
Finasteride—Neoplasm—Epirubicin—ovarian cancer	0.00101	0.0059	CcSEcCtD
Finasteride—Hypersensitivity—Chlorambucil—ovarian cancer	0.001	0.00586	CcSEcCtD
Finasteride—Rhinitis—Paclitaxel—ovarian cancer	0.000983	0.00575	CcSEcCtD
Finasteride—Asthenia—Chlorambucil—ovarian cancer	0.000976	0.0057	CcSEcCtD
Finasteride—Pharyngitis—Paclitaxel—ovarian cancer	0.000974	0.00569	CcSEcCtD
Finasteride—Hypotension—Vinorelbine—ovarian cancer	0.000968	0.00566	CcSEcCtD
Finasteride—Oedema peripheral—Paclitaxel—ovarian cancer	0.000966	0.00565	CcSEcCtD
Finasteride—Pruritus—Chlorambucil—ovarian cancer	0.000963	0.00562	CcSEcCtD
Finasteride—Urticaria—Topotecan—ovarian cancer	0.000962	0.00562	CcSEcCtD
Finasteride—Urticaria—Melphalan—ovarian cancer	0.000942	0.0055	CcSEcCtD
Finasteride—Neoplasm—Doxorubicin—ovarian cancer	0.000934	0.00546	CcSEcCtD
Finasteride—Dyspnoea—Vinorelbine—ovarian cancer	0.000924	0.0054	CcSEcCtD
Finasteride—Hypersensitivity—Topotecan—ovarian cancer	0.000892	0.00521	CcSEcCtD
Finasteride—Pain—Vinorelbine—ovarian cancer	0.000886	0.00518	CcSEcCtD
Finasteride—Immune system disorder—Paclitaxel—ovarian cancer	0.000886	0.00518	CcSEcCtD
Finasteride—Hypersensitivity—Melphalan—ovarian cancer	0.000874	0.00511	CcSEcCtD
Finasteride—Asthenia—Topotecan—ovarian cancer	0.000869	0.00508	CcSEcCtD
Finasteride—Mental disorder—Paclitaxel—ovarian cancer	0.000859	0.00502	CcSEcCtD
Finasteride—Pruritus—Topotecan—ovarian cancer	0.000857	0.00501	CcSEcCtD
Finasteride—Asthenia—Melphalan—ovarian cancer	0.000851	0.00497	CcSEcCtD
Finasteride—Progesterone—ESR1—ovarian cancer	0.00085	0.0708	CrCbGaD
Finasteride—Pruritus—Melphalan—ovarian cancer	0.000839	0.0049	CcSEcCtD
Finasteride—Rhinitis—Docetaxel—ovarian cancer	0.000834	0.00487	CcSEcCtD
Finasteride—Pharyngitis—Docetaxel—ovarian cancer	0.000825	0.00482	CcSEcCtD
Finasteride—Urticaria—Vinorelbine—ovarian cancer	0.000823	0.00481	CcSEcCtD
Finasteride—Oedema peripheral—Docetaxel—ovarian cancer	0.000819	0.00479	CcSEcCtD
Finasteride—Dizziness—Topotecan—ovarian cancer	0.000801	0.00468	CcSEcCtD
Finasteride—Angioedema—Paclitaxel—ovarian cancer	0.00078	0.00456	CcSEcCtD
Finasteride—Rash—Topotecan—ovarian cancer	0.000764	0.00446	CcSEcCtD
Finasteride—Hypersensitivity—Vinorelbine—ovarian cancer	0.000763	0.00446	CcSEcCtD
Finasteride—Dermatitis—Topotecan—ovarian cancer	0.000763	0.00446	CcSEcCtD
Finasteride—Headache—Topotecan—ovarian cancer	0.000759	0.00443	CcSEcCtD
Finasteride—Immune system disorder—Docetaxel—ovarian cancer	0.000751	0.00439	CcSEcCtD
Finasteride—Rash—Melphalan—ovarian cancer	0.000748	0.00437	CcSEcCtD
Finasteride—Dermatitis—Melphalan—ovarian cancer	0.000747	0.00437	CcSEcCtD
Finasteride—Asthenia—Vinorelbine—ovarian cancer	0.000743	0.00434	CcSEcCtD
Finasteride—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00074	0.00433	CcSEcCtD
Finasteride—Pruritus—Vinorelbine—ovarian cancer	0.000733	0.00428	CcSEcCtD
Finasteride—Breast disorder—Epirubicin—ovarian cancer	0.000733	0.00428	CcSEcCtD
Finasteride—Mental disorder—Docetaxel—ovarian cancer	0.000728	0.00426	CcSEcCtD
Finasteride—Influenza—Epirubicin—ovarian cancer	0.000701	0.00409	CcSEcCtD
Finasteride—Infection—Paclitaxel—ovarian cancer	0.000692	0.00405	CcSEcCtD
Finasteride—Dizziness—Vinorelbine—ovarian cancer	0.000685	0.004	CcSEcCtD
Finasteride—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000685	0.004	CcSEcCtD
Finasteride—Breast disorder—Doxorubicin—ovarian cancer	0.000678	0.00396	CcSEcCtD
Finasteride—Bronchitis—Epirubicin—ovarian cancer	0.000674	0.00394	CcSEcCtD
Finasteride—Rash—Vinorelbine—ovarian cancer	0.000653	0.00382	CcSEcCtD
Finasteride—Dermatitis—Vinorelbine—ovarian cancer	0.000653	0.00381	CcSEcCtD
Finasteride—Hypotension—Paclitaxel—ovarian cancer	0.000651	0.0038	CcSEcCtD
Finasteride—Headache—Vinorelbine—ovarian cancer	0.000649	0.00379	CcSEcCtD
Finasteride—Influenza—Doxorubicin—ovarian cancer	0.000648	0.00379	CcSEcCtD
Finasteride—Bronchitis—Doxorubicin—ovarian cancer	0.000623	0.00364	CcSEcCtD
Finasteride—Dyspnoea—Paclitaxel—ovarian cancer	0.000621	0.00363	CcSEcCtD
Finasteride—Somnolence—Paclitaxel—ovarian cancer	0.00062	0.00362	CcSEcCtD
Finasteride—Pain—Paclitaxel—ovarian cancer	0.000596	0.00348	CcSEcCtD
Finasteride—Infection—Docetaxel—ovarian cancer	0.000587	0.00343	CcSEcCtD
Finasteride—Sinusitis—Epirubicin—ovarian cancer	0.000586	0.00342	CcSEcCtD
Finasteride—Rhinitis—Epirubicin—ovarian cancer	0.000562	0.00329	CcSEcCtD
Finasteride—CYP3A5—uterine cervix—ovarian cancer	0.000561	0.0361	CbGeAlD
Finasteride—Pharyngitis—Epirubicin—ovarian cancer	0.000557	0.00325	CcSEcCtD
Finasteride—Urticaria—Paclitaxel—ovarian cancer	0.000554	0.00323	CcSEcCtD
Finasteride—Oedema peripheral—Epirubicin—ovarian cancer	0.000552	0.00323	CcSEcCtD
Finasteride—Hypotension—Docetaxel—ovarian cancer	0.000552	0.00323	CcSEcCtD
Finasteride—Sinusitis—Doxorubicin—ovarian cancer	0.000542	0.00317	CcSEcCtD
Finasteride—Dyspnoea—Docetaxel—ovarian cancer	0.000527	0.00308	CcSEcCtD
Finasteride—Somnolence—Docetaxel—ovarian cancer	0.000525	0.00307	CcSEcCtD
Finasteride—Rhinitis—Doxorubicin—ovarian cancer	0.00052	0.00304	CcSEcCtD
Finasteride—Pharyngitis—Doxorubicin—ovarian cancer	0.000515	0.00301	CcSEcCtD
Finasteride—Hypersensitivity—Paclitaxel—ovarian cancer	0.000513	0.003	CcSEcCtD
Finasteride—Oedema peripheral—Doxorubicin—ovarian cancer	0.000511	0.00299	CcSEcCtD
Finasteride—Immune system disorder—Epirubicin—ovarian cancer	0.000507	0.00296	CcSEcCtD
Finasteride—Pain—Docetaxel—ovarian cancer	0.000505	0.00295	CcSEcCtD
Finasteride—Asthenia—Paclitaxel—ovarian cancer	0.0005	0.00292	CcSEcCtD
Finasteride—Pruritus—Paclitaxel—ovarian cancer	0.000493	0.00288	CcSEcCtD
Finasteride—Mental disorder—Epirubicin—ovarian cancer	0.000491	0.00287	CcSEcCtD
Finasteride—Immune system disorder—Doxorubicin—ovarian cancer	0.000469	0.00274	CcSEcCtD
Finasteride—Dizziness—Paclitaxel—ovarian cancer	0.000461	0.00269	CcSEcCtD
Finasteride—Mental disorder—Doxorubicin—ovarian cancer	0.000455	0.00266	CcSEcCtD
Finasteride—Rash—Paclitaxel—ovarian cancer	0.000439	0.00257	CcSEcCtD
Finasteride—Dermatitis—Paclitaxel—ovarian cancer	0.000439	0.00257	CcSEcCtD
Finasteride—Headache—Paclitaxel—ovarian cancer	0.000437	0.00255	CcSEcCtD
Finasteride—Hypersensitivity—Docetaxel—ovarian cancer	0.000435	0.00254	CcSEcCtD
Finasteride—Asthenia—Docetaxel—ovarian cancer	0.000424	0.00248	CcSEcCtD
Finasteride—Pruritus—Docetaxel—ovarian cancer	0.000418	0.00244	CcSEcCtD
Finasteride—Infection—Epirubicin—ovarian cancer	0.000396	0.00231	CcSEcCtD
Finasteride—Dizziness—Docetaxel—ovarian cancer	0.000391	0.00228	CcSEcCtD
Finasteride—CYP3A5—female gonad—ovarian cancer	0.000382	0.0246	CbGeAlD
Finasteride—CYP3A5—vagina—ovarian cancer	0.00038	0.0245	CbGeAlD
Finasteride—Rash—Docetaxel—ovarian cancer	0.000372	0.00218	CcSEcCtD
Finasteride—Hypotension—Epirubicin—ovarian cancer	0.000372	0.00218	CcSEcCtD
Finasteride—Dermatitis—Docetaxel—ovarian cancer	0.000372	0.00217	CcSEcCtD
Finasteride—Headache—Docetaxel—ovarian cancer	0.00037	0.00216	CcSEcCtD
Finasteride—Infection—Doxorubicin—ovarian cancer	0.000366	0.00214	CcSEcCtD
Finasteride—Progesterone—ABCB1—ovarian cancer	0.000361	0.0301	CrCbGaD
Finasteride—Dyspnoea—Epirubicin—ovarian cancer	0.000355	0.00208	CcSEcCtD
Finasteride—Somnolence—Epirubicin—ovarian cancer	0.000354	0.00207	CcSEcCtD
Finasteride—Hypotension—Doxorubicin—ovarian cancer	0.000344	0.00201	CcSEcCtD
Finasteride—Testosterone—ABCB1—ovarian cancer	0.000341	0.0284	CrCbGaD
Finasteride—Pain—Epirubicin—ovarian cancer	0.000341	0.00199	CcSEcCtD
Finasteride—Dyspnoea—Doxorubicin—ovarian cancer	0.000329	0.00192	CcSEcCtD
Finasteride—Somnolence—Doxorubicin—ovarian cancer	0.000328	0.00191	CcSEcCtD
Finasteride—Urticaria—Epirubicin—ovarian cancer	0.000317	0.00185	CcSEcCtD
Finasteride—Pain—Doxorubicin—ovarian cancer	0.000315	0.00184	CcSEcCtD
Finasteride—CYP3A4—female reproductive system—ovarian cancer	0.000315	0.0203	CbGeAlD
Finasteride—Hypersensitivity—Epirubicin—ovarian cancer	0.000294	0.00172	CcSEcCtD
Finasteride—Urticaria—Doxorubicin—ovarian cancer	0.000293	0.00171	CcSEcCtD
Finasteride—Asthenia—Epirubicin—ovarian cancer	0.000286	0.00167	CcSEcCtD
Finasteride—Pruritus—Epirubicin—ovarian cancer	0.000282	0.00165	CcSEcCtD
Finasteride—Hypersensitivity—Doxorubicin—ovarian cancer	0.000272	0.00159	CcSEcCtD
Finasteride—Asthenia—Doxorubicin—ovarian cancer	0.000265	0.00155	CcSEcCtD
Finasteride—Dizziness—Epirubicin—ovarian cancer	0.000263	0.00154	CcSEcCtD
Finasteride—Pruritus—Doxorubicin—ovarian cancer	0.000261	0.00152	CcSEcCtD
Finasteride—Rash—Epirubicin—ovarian cancer	0.000251	0.00147	CcSEcCtD
Finasteride—Dermatitis—Epirubicin—ovarian cancer	0.000251	0.00147	CcSEcCtD
Finasteride—Headache—Epirubicin—ovarian cancer	0.00025	0.00146	CcSEcCtD
Finasteride—Dizziness—Doxorubicin—ovarian cancer	0.000244	0.00142	CcSEcCtD
Finasteride—Rash—Doxorubicin—ovarian cancer	0.000232	0.00136	CcSEcCtD
Finasteride—Dermatitis—Doxorubicin—ovarian cancer	0.000232	0.00136	CcSEcCtD
Finasteride—Headache—Doxorubicin—ovarian cancer	0.000231	0.00135	CcSEcCtD
